In this study, we reported that paclitaxel treatment significantly increased the CXCL1 protein cargo in EV‐Apo, which promoted the invasion and chemoresistance of breast cancer cells by polarizing M2 macrophages via transcriptionally upregulating their PD‐L1 expression. The gene discussed is CXCL1; the disease is breast cancer.